| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8e43b4ca6b41ce9f54c9a895d474c81a |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08G73-028
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08G65-3332
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08G65-333
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08G65-329
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-645
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08G69-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08G73-0233 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08G65-333
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08G65-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08G69-48 |
| filingDate |
2006-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2012-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ea0e222388661ae55847546dbd0d8237
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a269b6824469d24371d0f60e228f78a7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7b22efc605866a47df5e354ca164a32e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_65d8bc22dc298e87b248937148a7d458
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b895e47ef5116c995b2eb9986920a7ce |
| publicationDate |
2012-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-101218280-B |
| titleOfInvention |
Polymeric derivative of cytidine metabolic antagonist |
| abstract |
To provide a derivative of a cytidine metabolic antagonist which can exert a high therapeutic effect at a low dose. [MEANS FOR SOLVING PROBLEMS] A polymeric derivative of a cytidine metabolic antagonist which comprises a polymeric compound having a polyethyleneglycol moiety and a polymer moiety having a carboxyl group in a side chain and a cytidine metabolic antagonist, which has such a structurethat the carboxyl group in the side chain of the polymeric compound and an amino group in the cytidine metabolic antagonist are bound together to form an amide bond. |
| priorityDate |
2005-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |